Clinuvel Pharmaceuticals Limited
General ticker "CLVLF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $380.9M (TTM average)
Clinuvel Pharmaceuticals Limited follows the US Stock Market performance with the rate: 13.6%.
Estimated limits based on current volatility of 1.5%: low 7.95$, high 8.17$
Factors to consider:
- Company pays dividends (annually): last record date 2025-09-05, amount 0.03$ (Y0.37%)
Short-term CLVLF quotes
Long-term CLVLF plot
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | AUD78.32MM | AUD88.18MM | AUD95.02MM |
| Operating Expenses | AUD33.43MM | AUD40.17MM | AUD49.28MM |
| Operating Income | AUD44.89MM | AUD48.01MM | AUD45.73MM |
| Non-Operating Income | AUD0.69MM | AUD2.67MM | AUD5.82MM |
| Interest Expense | AUD3.19MM | AUD4.45MM | AUD4.46MM |
| R&D Expense | AUD1.27MM | AUD0.00MM | AUD0.00MM |
| Income(Loss) | AUD45.58MM | AUD50.68MM | AUD51.55MM |
| Taxes | AUD14.97MM | AUD15.04MM | AUD15.38MM |
| Profit(Loss)* | AUD30.60MM | AUD35.64MM | AUD72.35MM |
| Stockholders Equity | AUD164.63MM | AUD203.01MM | AUD240.81MM |
| Inventory | AUD9.52MM | AUD10.63MM | AUD8.82MM |
| Assets | AUD193.71MM | AUD231.12MM | AUD271.75MM |
| Operating Cash Flow | AUD36.91MM | AUD37.05MM | AUD41.10MM |
| Capital expenditure | AUD1.03MM | AUD5.58MM | AUD0.30MM |
| Investing Cash Flow | AUD-1.03MM | AUD-29.03MM | AUD-47.72MM |
| Financing Cash Flow | AUD-2.24MM | AUD-3.57MM | AUD-2.94MM |
| Earnings Per Share** | AUD0.62 | AUD0.72 | AUD1.44 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.